Molecular Diagnostics
The following is a list of all tests available from the Division of
Molecular Diagnostics.
Click on a test to see more information, including specimen types accepted,
clinical significance, and type of analysis.
Section I: Microbiology, Virology, and Infectious Diseases
Core PCR Laboratory
The following tests are available from the Core PCR
Laboratory:
Lyme Disease
Cytomegalovirus (CMV)
Hepatitis C virus (HCV)
Hepatitis B virus (HBV)
Human T-cell lymphoma/leukemia virus-I (HTLV-I)
Human T-cell lymphoma/leukemia virus-II (HTLV-II)
Human immunodeficiency virus (HIV-I)
Quantitative hepatitis C virus (HCV)
Quantitative cytomegalovirus (CMV)
Influenza virus
Parainfluenza virus
Adenoviruses (Types 2 + 5)
HSV
VZV
HPV generic
HPV 6,11,16,18,31,33
Moraxella catarrhalis
Streptococcus pneumonia
Haemophilus influenza
Bordetella pertussis
Legionella spp.
For a list of tests in development within the Core PCR Laboratory, please
click here.
Magee-Womens Hospital Molecular Diagnostics Laboratory
The following tests are available from the Magee-Womens Hospital
Molecular Diagnostics Laboratory:
Chlamydia
Human parvovirus B19
Candida albicans
Candida glabrata
Candida parapsilosis
Candida tropicalis
Group B streptococcus
For a list of tests in development within the Magee-Womens Hospital
Molecular Diagnostics Laboratory, please click
here.
Section II: Anatomic and Transplant Pathology
Molecular Tissue Typing Laboratory
The following tests are available from the Molecular Tissue Typing
Laboratory:
HLA typing DRB - low resolution
HLA typing DRB - high resolution (subtyping)
HLA typing DQB
Bone marrow engraftment studies
HLA DR typing (Rapid test)
For a list of tests in development within the Molecular Tissue Typing
Laboratory, please click here.
In Situ Hybridization Laboratory
The following tests are available from the In Situ Hybridization
Laboratory:
HPV (Panel probe)
HPV 6 and 11 subtype probe
HPV 16 and 18 subtype probe
HPV 31, 32, and 33 subtype probe
Adenovirus probe
CMV probe
EBV probe
HSV probe
mRNA/Kappa chain restrictions
mRNA/Lambda chain restrictions
Y chromosome specific probe
Section III: Molecular Oncology
Molecular Oncology Laboratory
The following tests are available from the Molecular Oncology Laboratory:
Immunoglobin heavy chain gene rearrangement
Immunoglobin kappa light chain gene rearrangement
Immunoglobin lambda light chain gene rearrangement
T-cell receptor beta-chain gene rearrangement
bcl-2 gene rearrangement
c-myc gene rearrangement
neu gene rearrangement
c-myc gene amplification
int-2 gene amplification
N-myc gene amplification
EGFR gane amplification
t(9;22), bcr-abl translocation
t(9;22), bcr-abl (ALL variant) translocation
t(15;17), pml-rar translocation
t(1;19), pbxl-E2A translocation
Epstein-Barr virus terminal repeat DNA analysis
rar-alpha gene rearrangement
mll-1 gene rearrangement
For a list of tests in development within the Molecular Oncology Laboratory,
please click here.
Section IV: Molecular Genetics
PGI/CLSI Federated Diagnostic Molecular Genetics Laboratory
The following tests are available from the PGI/CLSI Federated Diagnostic
Molecular Genetics Laboratory:
Cystic fibrosis
Gaucher disease
Medium chain acyl dehydrogenase deficiency
Quantitative X-inactivation
Myotonic dystrophy
Sodium channelopathies
Chloride channelopathies
Duchenne/Becker muscular dystrophy
For a list of tests in development within the PGI/CLSI Federated Diagnostic
Molecular Genetics Laboratory, please click here
.
The University of Pittsburgh Medical Center is a participant in the
Reference Laboratory Alliance (RLA), a wholly owned subsidiary of the
Institute for Transfusion Medicine that offers laboratory and related services
formerly provided by Central Blood Bank, and administers and markets services
provided by major reference laboratories, including the UPMC, Magee-Womens
Hospital, Children's Hospital of Pittsburgh, Allegheny General Hospital, and
other laboratories supervised by the Pathology Education and Research
Foundation.
|